Skip to main content
Home / Current Medicinal Chemistry, Volume 17, Number 13
Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

More about this publication?
Volume 17, Number 13, 2010

Articles

New Opportunities to Treat the T315I-Bcr-Abl Mutant in Chronic Myeloid Leukaemia: Tyrosine Kinase Inhibitors and Molecules that Act by Alternative Mechanisms
pp. 1220-1245(26)
Authors: Schenone, S.; Brullo, C.; Botta, M.

Favourites:
ADD

Reversing Aberrant Methylation Patterns in Cancer
pp. 1246-1254(9)
Authors: Poke, F. S.; Qadi, A.; Holloway, A. F.

Favourites:
ADD

Targeting αvβ3 Integrin: Design and Applications of Mono- and Multifunctional RGD-Based Peptides and Semipeptides
pp. 1255-1299(45)
Authors: Auzzas, L.; Zanardi, F.; Battistini, L.; Burreddu, P.; Carta, P.; Rassu, G.; Curti, C.; Casiraghi, G.

Favourites:
ADD

Primate-Accelerated Evolutionary Genes: Novel Routes to Drug Discovery in Psychiatric Disorders
pp. 1300-1316(17)
Authors: Moalic, J. -M.; Le Strat, Y.; Lepagnol-Bestel, A. -M.; Ramoz, N.; Loe-Mie, Y.; Maussion, G.; Gorwood, P.; Simonneau, M.

Favourites:
ADD

Role of COL4A1 in Basement-Membrane Integrity and Cerebral Small-Vessel Disease. The COL4A1 Stroke Syndrome
pp. 1317-1324(8)
Authors: Volonghi, I.; Pezzini, A.; Del Zotto, E.; Giossi, A.; Costa, P.; Ferrari, D.; Padovani, A.

Favourites:
ADD

Coumarins: Old Compounds with Novel Promising Therapeutic Perspectives
pp. 1325-1338(14)
Authors: Riveiro, M. E.; De Kimpe, N.; Moglioni, A.; Vazquez, R.; Monczor, F.; Shayo, C.; Davio, C.

Favourites:
ADD

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content